Immunotherapy
CAR T Revolutionized How We Treat Blood Cancers. Now It's Closing In on Solid Tumors.
Posted in Medicine, Science on 16th Jul, 2026
by Alexander Muller
Unlike blood cancers, solid tumors rarely share one universal target, making it hard for engineered immune cells to consistently find and eliminate them.
Immunotherapy Shows Long-Term Promise in Aggressive Lymphoma
Posted in Medicine, Science on 14th Jul, 2026
by Alexander Muller
A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the journal Blood.
New Cancer Treatment Uses Modified Cells to Train the Immune System
Posted in Medicine, Science on 30th Jan, 2026
by Alexander Muller
However, this early work represents a promising direction in oncology, one that leverages the complexity of the immune system rather than relying solely on conventional therapies.
Why Don’t Cancer Immunotherapies Work for Everyone?
Posted in Medicine, Science on 26th Jan, 2024
by Alex Muller
A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders.
NHS offers first drug targeting advanced breast cancers driven by BRCA gene mutations
Posted in Medicine, Science on 26th Jan, 2024
by Alex Muller
Talazoparib (Talzenna) will become the NHS’s first targeted treatment for advanced breast cancers caused by mutations to BRCA genes